Why are UK stocks flat despite Healthcare strength?

Why are UK stocks flat despite Healthcare strength?
Rivanshi Rakhrai
15 Apr 2026, 12:40 PM

powered by

Invezz
Buy AstraZeneca (AZN.L) as defensive beta

Go long AstraZeneca (AZN.L). Healthcare is the only meaningful support (+1% in the sector) and AZN is leading that strength. With the FTSE 100 flat and investors waiting on macro/policy and geopolitical headlines, defensive earnings quality should keep AZN outperforming the index and limit downside versus cyclicals/financials.

Key Risk: A negative AZN-specific catalyst (trial/regulatory/commercial disappointment) or a sudden rotation out of defensives into cyclicals.

Sell FTSE 100 financials (HSBC, Prudential)

Short HSBC (HSBA.L) and Prudential (PRU.L). The article flags financials as the biggest drag (banks -0.4%, insurers -0.8%) while sentiment stays cautious on Middle East uncertainty and policy signals from Andrew Bailey. In this tape, risk-off flows and rate-path ambiguity typically compress bank/insurer multiples and raise credit/volatility premia—so the sector’s relative weakness should persist even as healthcare offsets the index.

Key Risk: A clear dovish/benign Bailey signal plus a rapid de-escalation in Middle East risk that triggers a broad financials rerating.

  • FTSE 100 stays flat as investors track Middle East tensions.
  • Financial and energy stocks drag, healthcare provides support.
  • Corporate updates and policy signals remain key market focus.

London equities opened on a cautious note on Wednesday, with the benchmark index struggling for direction as losses in heavyweight financial and energy stocks offset gains in healthcare.

Investor sentiment remained restrained amid mixed signals surrounding the Middle East conflict, keeping the index largely flat in early trade.


FTSE 100 holds steady amid sectoral weakness

The blue-chip FTSE 100 was flat at 10,611.03 points by 0957 GMT.

Meanwhile, the mid-cap FTSE 250 slipped 0.1%, reflecting a subdued tone across broader UK equities.

Market participants remained cautious as they evaluated conflicting developments surrounding the Iran conflict.

US President Donald Trump indicated that peace talks could resume this week.

However, this optimism was tempered by Washington’s decision to halt Tehran’s maritime trade, adding to uncertainty.

Financials and energy stocks lead declines

Financial stocks emerged as the biggest drag on the FTSE 100.

Banking stocks declined 0.4%, while life insurers fell 0.8%.

Among individual stocks, HSBC dropped 0.6%, while Prudential lost 1.8%, weighing heavily on the index.

Energy stocks also edged lower, tracking relatively stable oil prices.

Oil remained below $100 per barrel, offering little support to the sector.

British energy stocks slipped 0.1%, contributing further to the market’s muted performance.

Healthcare sector offers support

On the positive side, healthcare stocks provided some relief to the index.

The sector recorded gains, with AstraZeneca rising 1%, helping offset broader declines.

The personal goods sector, however, was the worst performer in percentage terms.

This was largely due to a 1.3% drop in Burberry, following disappointing results from peers Kering and Hermès, which dampened investor sentiment.

Focus shifts to policy signals and earnings

Investors were also awaiting comments from Andrew Bailey, which are expected later in the day.

His remarks will likely be closely analysed for clues on the central bank’s policy outlook.

In addition, market participants are increasingly turning their attention to corporate earnings and updates.

Companies’ strategies to navigate headwinds stemming from the Middle East conflict remain a key focus area.

Corporate movers provide bright spots

Despite the broader subdued market, some individual stocks posted notable gains.

Antofagasta led the FTSE 100 with a 2.9% rise after stating that copper production is expected to increase quarter-on-quarter throughout the year.

Meanwhile, Saga surged 10.7%.

The company said it is ahead of schedule in achieving its medium-term profit targets, boosting investor confidence.

Shares of Barratt Redrow also rose 1.6%, even after the firm announced cuts to its land spending and approval targets.

The move suggested a cautious approach, but investors appeared encouraged by its broader outlook.

Overall, the UK market remained range-bound, with geopolitical developments and corporate signals continuing to shape investor sentiment.